<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>Anthony Ricco, MD</title>
<meta content="Personal site of Anthony Ricco, documenting work, notes, and experiments." name="description"/>
<link href="assets/logo.svg" rel="icon" type="image/svg+xml"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Mono:wght@400;600;700&amp;display=swap" rel="stylesheet"/>
<link href="style.css" rel="stylesheet"/>
</head>
<body>
<header class="site-header">
<h1><a href="/">Anthony Ricco, MD</a></h1>
</header>
<main>
<section aria-label="About" class="intro">
      <p>Radiation oncologist dedicated to Main Line Health, pairing stereotactic expertise with compassionate guidance so every patient understands their path forward.</p>
      <p>I design treatment courses that blend precision imaging, motion management, and supportive care—helping families navigate decisions with clarity and confidence.</p>
      <p>My research explores cardiotoxicity surveillance, repeat lung irradiation, and survivorship outcomes, with regular ASTRO talks translating data into everyday practice.</p>
<div class="intro-meta">
<span class="last-updated">Last updated: <time datetime="2025-10-04">Oct 4, 2025</time></span>
<nav aria-label="Primary links" class="meta-links">
<a href="mailto:hello@anthonyrico.com">Email</a>
<a href="https://github.com/anthonyrico" rel="noopener" target="_blank">GitHub</a>
<a href="https://www.linkedin.com/in/anthonyrico" rel="noopener" target="_blank">LinkedIn</a>
<a href="https://x.com/anthonyrico" rel="noopener" target="_blank">X</a>
<a href="/rss.xml">RSS</a>
<a href="assets/Anthony-Ricco-CV-2024.pdf" rel="noopener" target="_blank">CV</a>
<a href="https://www.google.com/maps/place/Anthony+Ricco,+MD" rel="noopener" target="_blank">Google Reviews</a>
</nav>
</div>
</section>
<section aria-label="Curriculum vitae" class="cv" id="cv">
<h2>Curriculum vitae</h2>
<div class="cv-contact">
<p><strong>Anthony Ricco, M.D.</strong></p>
<p>Phone: <a href="tel:+16108649053">(610) 864-9053</a> · Email: <a href="mailto:anthony.g.ricco@gmail.com">Contact</a></p>
</div>
<section class="cv-section">
<h3>Education &amp; Training</h3>
<ul class="cv-list cv-education">
<li>
<div class="cv-entry">
<span class="cv-entry-title">Main Line Health — Lankenau and Riddle Hospitals (Wynnewood, PA)</span>
<span class="cv-entry-meta">Staff Radiation Oncologist · Mar 2023 – Present</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">Precision Radiation Oncology — Phoenixville Hospital (Phoenixville, PA)</span>
<span class="cv-entry-meta">Staff Radiation Oncologist · Oct 2022 – Feb 2023</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">Precision Radiation Oncology — Crozer Chester Medical Center (Glen Mills, PA)</span>
<span class="cv-entry-meta">Staff Radiation Oncologist · Mar 2022 – Feb 2023</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">Comprehensive Cancer Care (Exton, PA)</span>
<span class="cv-entry-meta">Staff Radiation Oncologist · Jul 2021 – Feb 2022</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">Virginia Commonwealth University (Richmond, VA)</span>
<span class="cv-entry-meta">Radiation Oncology Resident · Jul 2017 – Jun 2021</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">Crozer Chester Medical Center (Chester, PA)</span>
<span class="cv-entry-meta">Transitional Year Intern · Jul 2016 – Jun 2017</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">Sidney Kimmel Medical College at Thomas Jefferson University (Philadelphia, PA)</span>
<span class="cv-entry-meta">MD, Population Health & Urban Underserved Programs · Jul 2012 – May 2016</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">American Board of Obesity Medicine</span>
<span class="cv-entry-meta">Certification · 2023</span>
</div>
</li>
<li>
<div class="cv-entry">
<span class="cv-entry-title">The Pennsylvania State University (State College, PA)</span>
<span class="cv-entry-meta">BS, Neuroscience · Global Health · Humanitarian Engineering · Sep 2009 – May 2012</span>
</div>
</li>
</ul>
</section>
<div class="cv-accordion">
<details class="cv-details">
<summary>Technical Experience</summary>
<ul>
<li>External Beam Radiation Therapy (EBRT)</li>
<li>IMRT, VMAT with RapidARC, and 3D-CRT</li>
<li>IGRT (Gold Fiducial, Cone-Beam CT) and SGRT (Vision RT)</li>
<li>Special Techniques: Total Body Irradiation, Total Skin Electron Therapy (rotational), Craniospinal Irradiation</li>
<li>Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS)</li>
<li>LINAC-Based</li>
<li>Brachytherapy</li>
<li>HDR: Gynecology, Prostate, Sarcoma, Breast</li>
<li>LDR: Prostate, CivaSheet</li>
<li>Simulation and Treatment Planning Systems</li>
<li>Helical, Breath Hold, and 4D CT Simulation</li>
<li>Pinnacle, Eclipse, Brainlab, MIM, Variseed</li>
<li>Radiopharmaceuticals</li>
<li>Radioembolization - Y90</li>
</ul>
</details>
<details class="cv-details">
<summary>Activities &amp; Awards</summary>
<ul>
<li>Chief Resident (2020-2021)</li>
<li>"Learners as Teachers" Training, Stanford Clinical Teaching Model (2020)</li>
<li>Graduate Medical Education Committee, Virginia Commonwealth University Health (2019-Present)</li>
<li>Graduate Medical Education, Virginia Commonwealth University Health (2018-Present)</li>
<li>Clinical Trials in Radiation Oncology Workshop, University of Pennsylvania (2018)</li>
<li>ASTRO-NIH Immunotherapy Workshop, National Institutes of Health (2017)</li>
<li>Professional Memberships (2017-Present): American Brachytherapy Society; American Society for Radiation Oncology; American Society of Clinical Oncology</li>
<li>Radiation Oncology Award, Sidney Kimmel Medical College (2016)</li>
<li>Student Leadership Forum, Sidney Kimmel Medical College (2013)</li>
<li>Annenberg Anatomy Competition, Honorable Mention (2012)</li>
<li>The President's Freshman Award, The Pennsylvania State University (2011)</li>
</ul>
</details>
<details class="cv-details">
<summary>Licensure</summary>
<ul>
<li>ACR Board Certification</li>
<li>Full Medical License, Pennsylvania/Delaware (2021-Present)</li>
<li>Resident Training License, Virginia Department of Health Professions (Spring 2013)</li>
<li>Resident Training License, Pennsylvania (Spring 2009)</li>
</ul>
</details>
<details class="cv-details">
<summary>Publications</summary>
<ol>
<li>Ricco, Anthony, McLaughlin C, Mukhopadhyay N, Skoro N, Selamawit G, Deng X, Song S, et al. Patient Survival with and without radiotherapy for Early Stage Diffuse Large B Cell Lymphoma in the Era of PET/CT and Rituximab. Pending publication.</li>
<li>Ricco, Anthony, Moghanaki Drew, Anscher Mitchell, Chang Michael, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/32974208/" rel="noopener" target="_blank">Moderately Hypofractionated Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost for Prostate Cancer</a>: Five-Year Toxicity Results from a Prospective Phase I/II Trial. Front Oncol. 2020;10: 1686.</li>
<li>Ricco, Anthony, Slade A, Canada J, Grizzard J, Dana F, Reza-Gharai L, Neiderer K, Vera A, Abbate A, Weiss E. <a href="https://pubmed.ncbi.nlm.nih.gov/32626602/" rel="noopener" target="_blank">Cardiac MRI utilizing late gadolinium enhancement (LGE) and T1 mapping in the detection of radiation induced heart disease</a>. Cardiooncology. 2020;6: 6.</li>
<li>Ricco, Anthony, Barlow S, Jacob J, Feng J, Hanlon A, Arrigo S, Obayomi-Davies O, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/35739135/" rel="noopener" target="_blank">Long-Term Outcomes Following Repeat Radiation (RT) to the Lung for Lung Cancer and Lung Metastases with Stereotactic Body Radiation Therapy (SBRT)</a>. Advances in Radiation Oncology. 2020;5: 984-993.</li>
<li>Ricco, Anthony, Barbera G, Lanciano R, Feng J, Hanlon A, Lozano A, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/33102201/" rel="noopener" target="_blank">Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer</a>: A Single Institutional Experience With Long-Term Follow-Up. Front Oncol. 2020;10: 1505.</li>
<li>Ricco, Anthony, Alexandra Hanlon, and Rachelle Lanciano. 2017. "<a href="https://pubmed.ncbi.nlm.nih.gov/28913176/" rel="noopener" target="_blank">Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for Localized Prostate Cancer</a>: A Survival Analysis from the National Cancer Database." Frontiers in Oncology 7 (August): 185.</li>
<li>Ricco, Anthony, Joanne Davis, William Rate, Jun Yang, David Perry, John Pablo, David D'Ambrosio, et al. 2017. "<a href="https://pubmed.ncbi.nlm.nih.gov/28143558/" rel="noopener" target="_blank">Lung Metastases Treated with Stereotactic Body Radiotherapy: The RSSearch(R)</a> Patient Registry's Experience." Radiation Oncology 12 (1): 35.</li>
<li>Ricco, Anthony, Genevieve Manahan, Rachelle Lanciano, Alexandra Hanlon, Jun Yang, Stephen Arrigo, John Lamond, et al. 2016. "<a href="https://pubmed.ncbi.nlm.nih.gov/27602330/" rel="noopener" target="_blank">The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups</a>." Frontiers in Oncology 6 (August): 184.</li>
<li>Zaorsky, Nicholas G., Ricco, Anthony, Thomas M. Churilla, Eric M. Horwitz, and Robert B. Den. 2016. "<a href="https://pubmed.ncbi.nlm.nih.gov/27470145/" rel="noopener" target="_blank">ASTRO APEx(R)</a> and RO-ILSTM Are Applicable to Medical Malpractice in Radiation Oncology." Future Oncology 12 (22): 2643-57.</li>
<li>Ahmad S, Ricco Anthony, Brown R, Hanlon A, Yang J, Feng J, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/28337424/" rel="noopener" target="_blank">Single Institutional Experience of Stereotactic Radiosurgery Alone for First Brain Metastatic Event</a> and Salvage of Second Brain Metastatic Event in a Community Setting with Review of the Literature. Front Oncol. 2017;7: 32.</li>
<li>Ricco Anthony, Manahan G, Lanciano R, Hanlon A, Yang J, Arrigo S, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/27602330/" rel="noopener" target="_blank">The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups</a>. Front Oncol. 2016;6: 184.</li>
<li>Hasan S, Ricco Anthony, Jenkins K, Lanciano R, Hanlon A, Lamond J, et al. <a href="https://pubmed.ncbi.nlm.nih.gov/27921006/" rel="noopener" target="_blank">Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy</a>. Front Oncol. 2016;6: 249.</li>
<li>Ricco, Anthony, Rachelle Lanciano, and Alexandra Hanlon. 2016. "<a href="https://pubmed.ncbi.nlm.nih.gov/27083624/" rel="noopener" target="_blank">Predictors of Long-Term Survival for Localized Prostate Cancer Treated with High-Dose IMRT Stratified by NCCN 2015 Guidelines</a> in a Community Hospital Setting." Journal of Radiation Oncology 5 (1): 95-101.</li>
</ol>
</details>
<details class="cv-details">
<summary>Clinical Trials</summary>
<ul>
<li>2018-2020 · Protocol #MCC-16-12436: Phase II Trial of Stereotactic Radiotherapy and PD-1 Inhibiting Therapy for the Treatment of Solid Tumors after Progression on PD-1 Inhibiting Therapy — Co-Investigator</li>
<li>2017-2020 · Protocol #HM20004955: Phase IIa trial of low dose radiation therapy to reduce cerebral amyloidosis in early Alzheimer's dementia — Co-Investigator</li>
</ul>
</details>
<details class="cv-details">
<summary>Selected Presentations</summary>
<ol>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.1230" target="_blank" rel="noopener">Ricco AG, Rezai Gharai L, Kalman N, Weiss E. Interstitial Lung Disease Subtypes and Severity of Pulmonary Emphysema: Relation to Radiographic Lung Changes and Radiation Pneumonitis after Stereotactic Body Radiation Therapy. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.1275" target="_blank" rel="noopener">Ricco AG, Allen A, Kalman N, Weiss E. The association between laboratory pretreatment immune parameters and radiographic lung changes in early stage lung cancer patients undergoing stereotactic body radiation therapy. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.1247" target="_blank" rel="noopener">Ricco AG, McDonagh PR, Guy CL, Weiss E. Pre-, Intra-, and Post-treatment Serum Albumin Predicts for Clinical Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients treated with Radiochemotherapy. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.1079" target="_blank" rel="noopener">Ricco AG, Kim A, Canada J, Grizzard J, Dana F, Rezai Gharai L, Abbate A, Weiss E. Extracellular Volume Fraction of Cardiac MRI in the Detection of Cardiac Toxicity from Radiotherapy. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.2309" target="_blank" rel="noopener">Ricco AG, McLaughlin, Allen A, Singh R, Mukhopadhyay N, Song S. Early Stage Diffuse Large B Cell Lymphoma in the Era of PET and Rituximab: Benefits from Radiotherapy in all NCCN International Prognostic Index Risk Groups. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.1207" target="_blank" rel="noopener">Cooper DA, Ricco AG, Rezai Gharai L, Guy CL, Weiss E. Risk of Radiation Pneumonitis in Locally Advanced Lung Cancer Patients: Role of Interstitial Lung Disease Subtypes and Severity of Pulmonary Emphysema. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.462" target="_blank" rel="noopener">Urdaneta AI, Schutzer ME, Ritter TA, Neiderer K, Ricco AG, Todor DA. A novel prostate SBRT vs HDR comparison: A disease perspective. ASTRO, 2020.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2020.07.515" target="_blank" rel="noopener">Barbera G, Ricco AG, Lanciano R, Feng J, Hanlon A, Lozano A, Good M, Arrigo S, Lamond J, Yang J. Favorable Biochemical Relapse Free Survival at 10 years following Stereotactic Body Radiation Therapy (SBRT) for Intermediate and High-Risk Prostate Cancer. ASTRO, 2020.</a></li>
          <li>Rosu-Bubulac M, Ricco AG, Urdaneta A, Kim S, Weiss E, Palta J. Can Rectum Stability Issues Be Managed with IGRT in Prostate Radiotherapy? American Association of Physicists in Medicine Meeting, 2020.</li>
          <li>Ricco AG, Barlow S, Jacob J, Singh R, Feng J, Hanlon A, Arrigo S, Obayomi-Davies O, et al. Long Term Outcomes following Three or More Courses of Repeat Lung Radiation using Stereotactic Body Radiation Therapy. Radiosurgical Society Meeting, 2020.</li>
          <li>Ricco AG, Urdaneta A, Kim S, Rosu-Bubulac M. A retrospective analysis of image guided radiotherapy for prostate cancer: rectal dosimetric consequences of different alignment paradigms. American College of Radiation Oncology Meeting, 2020.</li>
          <li><a href="https://doi.org/10.1200/jco.2020.38.6_suppl.299" target="_blank" rel="noopener">Ricco AG, Mukhopadhyay N, Holdford D, Skinner V, Saraiya S, Moghanaki D, Anscher M, Chang M. Five year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage. Genitourinary American Society of Clinical Oncology Meeting, 2020.</a></li>
          <li>Todor D, Urdaneta A, Ricco AG. The insider view on differences between CT and US prostate HDR: A tumorlet perspective. World Congress of Brachytherapy, 2020.</li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2019.06.2394" target="_blank" rel="noopener">Ricco AG, Slade AN, Canada J, Grizzard J, Dana F, Gharai LR, et al. T1 Mapping and Cardiac MRI in the Detection of Cardiac Toxicity from Radiotherapy. Int J Radiat Oncol Biol Phys. 2019;105: E58.</a></li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2019.06.1169" target="_blank" rel="noopener">Ricco AG, Barlow S, Jacob J, Feng J, Hanlon A, Arrigo SA, et al. Long Term Outcomes Following Repeat Radiation Therapy (RT) to the Lung for Lung Cancer and Lung Metastases with Stereotactic Body Radiation Therapy (SBRT). Int J Radiat Oncol Biol Phys. 2019;105: E583-E584.</a></li>
          <li>Ricco AG, Canada J, Grizzard J, Dana F, Gharai LR, Neiderer K, et al. Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR). Int J Radiat Oncol Biol Phys. 2018;102: S224-S225.</li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2018.07.310" target="_blank" rel="noopener">Guilday SP, Dziemianowicz M, Ricco AG, Lanciano RM, Hanlon A, Feng J, et al. Stereotactic Body Radiation Therapy (SBRT) for Intermediate and High-Risk Prostate Cancer: Early Adoption in a Community Hospital Setting. Int J Radiat Oncol Biol Phys. 2018;102: e113-e114.</a></li>
          <li>Ricco AG, Davis, J, Yang J, Rate W, Lanciano RM. Lung Oligometastases treated with SBRT: the RSSearch Registry's 10-year Experience. The Radiosurgery Society Meeting, 2015.</li>
          <li><a href="https://doi.org/10.1016/j.ijrobp.2015.07.1096" target="_blank" rel="noopener">Manahan G, Ricco AG, Bernetich M, Lanciano RM, Yang J, Hanlon A, et al. The Equivalence of Stereotactic Body Radiation Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer Stratified by 2015 NCCN Risk Groups. Int J Radiat Oncol Biol Phys. 2015;93: E217.</a></li>
          <li>Ricco AG., Zaorsky, N., Den, R. (2016). Medical malpractice in radiation oncology: a case series. American Radium Society, 2016.</li>
          <li>Ricco AG, Thornton, S., Lanciano, R., Brady, L. (2016). Acute toxicity and dose sparing of organs at risk using SBRT for orbital tumors. American Radium Society, 2016.</li>
          <li>Ricco AG, Ahmed, S., Lanciano, R., Brady, L. (2015). A case of an adult with Ewing Sarcoma declining chemotherapy presenting with globe-displacing frontal bone metastasis. Pennsylvania Society of Hematology and Oncology, 2016.</li>
          <li><a href="https://doi.org/10.3389/fonc.2016.00249" target="_blank" rel="noopener">Hasan, S., G., Ricco AG, Lanciano, R., Hanlon, A., Lamond, J., Yang, J., Feng, J., Good, M., Noumoff, J., Brady, L. (2015). Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy. ASTRO, 2015.</a></li>
          <li>Ahmad, S., Ricco AG, Brown, R., Lanciano, R., Hanlon, A., Heal, C., Yang, J., Feng, J., Stanley, M., Buonocore, R., Okpaku, A., Ding, W., Arrigo, S., Lamond, J., Brady, L. (2016). Efficacy of Cyberknife Delivered Stereotactic Radiosurgery (SRS) for Brain Metastases: Is there a Difference in Survival between First and Second Brain Metastatic Event?</li>
</ol>
</details>
</div>
</section>
</main>
</body>
</html>
